PAH and pulmonary arterial hypertension: Thirdly, data obtained from computer simulation and experimental verification demonstrated that neomangiferin could stabilize PAH-BH4 interaction through competitive binding with PAH, effectively attenuating DOX-induced PAH inhibition while preserving enzymatic activity.